Overview of Euphyllin retard N
| Property | Description |
|---|---|
| Active ingredient | Theophylline |
| Form | Sustained-Release Tablet (Retard Tablet) |
| Pharmacological class | Xanthine Derivative / Bronchodilator |
| Common use | Long-term breathing support |
| Origin | Synthetic |
What is Euphyllin retard N and Its Active Ingredient?
Euphyllin retard N is a brand name for an oral medicine that contains the single active ingredient Theophylline, which is chemically classified as a Xanthine derivative. This compound is a synthetic drug widely recognized for its function as a bronchodilator, helping to widen the air passages in the lungs.
Theophylline is an established drug that has been clinically recognized for decades to provide symptomatic relief in chronic respiratory disorders. The product is typically sold as a prescription-only (Rx) medication used for long-term management.
How is Euphyllin retard N Classified?
The medicine is supplied in the sustained-release (retard) tablet dosage form for oral administration. The specialized "retard" formulation is its key feature, designed to control the rate at which Theophylline is released into the body.
This design ensures that the active substance is released slowly and steadily over many hours, which helps maintain a continuous, stable concentration in the body. This modified-release approach is designed to provide consistent support for breathing.
What is the General Purpose of This Medicine?
The general purpose of Euphyllin retard N is to provide reliable, long-term maintenance support for respiratory stability. It achieves this by acting as a smooth muscle relaxant on the involuntary muscles that surround the bronchial tubes.
This action, known as bronchodilation, supports stable and consistent airflow. A typical use scenario involves a patient taking the tablet to help prevent daily and nightly episodes of shortness of breath by keeping the airways consistently open.
Regulatory References
